首页> 美国卫生研究院文献>Clinical and Molecular Hepatology >Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

【2h】

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

机译：高效聚乙二醇干扰素α-2a联合利巴韦林联合治疗韩国慢性血友病中的丙型肝炎

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimsChronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. However, there are no published data on the efficacy of antiviral therapy in Korea. We assessed the safety and efficacy of combination therapy with peginterferon α-2a plus ribavirin for CHC in hemophilia.

机译：背景/目标慢性丙型肝炎（CHC）是血友病患者的主要合并症。但是，韩国尚无抗病毒治疗功效的公开数据。我们评估了聚乙二醇干扰素α-2a加利巴韦林联合治疗血友病中CHC的安全性和有效性。

著录项

期刊名称 Clinical and Molecular Hepatology
作者
Suh Yoon Yang; Hyun Woong Lee; Youn Jae Lee; Sung Jae Park; Ki Young Yoo; Hyung Joon Kim;
展开▼
作者单位

展开▼
年(卷),期 2015(21),2
年度 2015
页码 125–130
总页数 6
原文格式 PDF
正文语种
中图分类分子生物学;
关键词
Chronic hepatitis C Hemophilia Peginterferon Ribavirin;

机译：慢性丙型肝炎;血友病;聚乙二醇干扰素;利巴韦林;

相似文献

外文文献
中文文献
专利

1. Superiority of peginterferon α-2a and ribavirin combination over peginterferon α-2a monotherapy in the management of hemodialysis patients with chronic Hepatitis C virus infection [J] . Saeed M.G Al-Ghamdi, Nasser Alaulaqi, Abdullah A Al-Amoudi, Saudi journal of kidney diseases and transplantation : . 2017,第4期

机译：聚乙二醇干扰素α-2a和利巴韦林联用优于聚乙二醇干扰素α-2a单药治疗慢性丙型肝炎病毒感染的血液透析患者
2. Superiority of peginterferon α-2a and ribavirin combination over peginterferon α-2a monotherapy in the management of hemodialysis patients with chronic Hepatitis C virus infection [J] . Saeed M.G Al-Ghamdi, Nasser Alaulaqi, Abdullah A Al-Amoudi, Saudi journal of kidney diseases and transplantation : . 2017,第4期

机译：聚乙二醇干扰素α-2a和利巴韦林联用优于聚乙二醇干扰素α-2a单药治疗慢性丙型肝炎病毒感染的血液透析患者
3. Peginterferon α-2a Combination Therapies in Chronic Hepatitis C Patients Who Relapsed After or Had a Viral Breakthrough on Therapy with Standard Interferon α-2b Plus Ribavirin: A Pilot Study of Efficacy and Safety [J] . Steven K. Herrine MD, Robert S. Brown Jr. MD, David E. Bernstein MD, Digestive Diseases and Sciences . 2005,第4期

机译：接受标准干扰素α-2b加利巴韦林治疗的慢性丙型肝炎患者中或病毒突破后复发的聚乙二醇干扰素α-2a联合疗法：有效性和安全性的初步研究
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. Ribavirin systemic and intracellular exposure and its role on viral response and anemia in chronic hepatitis c genotype 1 infection [D] . Wu, Liviawati Sutjandra. 2015

机译：利巴韦林全身和细胞内暴露及其在慢性丙型肝炎基因型1感染中对病毒反应和贫血的作用
6. High Rate of Virological Response to Peginterferon α-2a–Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C [O] . Mostafa Alavi Moghaddam, Mohammad Reza Zali, Seyed Hossein Aalaei Andabili, 2012

机译：非肝硬化伊朗丙型肝炎血友病患者对聚乙二醇干扰素α-2a-利巴韦林的病毒学应答率较高
7. Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea [O] . Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, 2015

机译：高效聚乙二醇干扰素α-2a加利巴韦林联合治疗韩国血友病慢性丙型肝炎

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

摘要

著录项

相似文献

相关主题

期刊订阅